Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis.

Tigran Makunts Haroutyun Joulfayan Ruben Abagyan

Published in: JMIRx med (2024)

GLP-1 RAs, regardless of indication, are associated with an over 10-fold increase in thyroid neoplasm and hyperplasia adverse event reporting when compared to SGLT-2 inhibitors.

Keyphrases

adverse drug
drug administration
low grade
electronic health record
emergency department
drug induced
wild type
climate change